Camtek (CAMT) Director Stav Orit Receives RSUs and Option Awards

What Happened
Stav Orit, a director of Camtek Ltd. (CAMT), received two equity awards on July 29, 2026: 254 restricted stock units (RSUs) and 571 derivative awards (stock options or option-like awards). Both awards were reported at $0.00 acquisition price (i.e., no cash paid at grant). The RSUs and the options are contingent on continued service and vest on the date of Camtek’s 2027 annual meeting of shareholders.

Key Details

• Transaction date: 2026-07-29; Form 4 filed 2026-07-30 (filed the next day).
• Reported price: $0.00 for both grants; total immediate cash value reported as $0.
• Grants: 254 RSUs (each represents a contingent right to one share) and 571 derivative awards (options to purchase shares).
• Vesting: Both the RSUs and the options will vest on the Company’s 2027 annual meeting date, subject to continued service (per footnotes F1–F3).
• Shares owned after transaction: Not provided in the excerpt you supplied. Check the full Form 4 for post-transaction beneficial ownership.
• No sale or exercise reported—these are grants (compensation/retention), not purchases or dispositions.

Context

• RSUs: Each RSU converts to one share upon vesting; they do not represent immediate voting shares until settled.
• Options/Derivative awards: Give the right to buy shares at a specified exercise price when/if vested and exercised; the exercise price and any future exercise activity were not included in the provided excerpt.
• Interpretation for investors: Director grants are common as compensation or retention and do not necessarily signal the director is buying or selling stock. Grants can lead to future dilution when vested/settled—watch future filings for vesting, exercises, or any related sales.